home.aspx
 
. https://www.technologynetworks.com/tn/news/can-a-genetic-test-predict-opioid-addiction-risk-328461
blog article
SHARESHARESHARE
CAN GENETIC TESTING PREDICT OPIOID ADDICTION RISK?
Prescient Medicine Holdings, Inc. and the Department of Clinical Chemistry at Erasmus MC (CC-EMC), Rotterdam announced a partnership for CC-EMC to study opioid addiction risk in The Netherlands. The partnership will center on Prescient Medicine's novel genetic testing technology designed to objectively assess an individual's risk of opioid addiction prior to opioid exposure. The clinical research will be conducted with patients in The Netherlands to confirm that the positive results from research completed in the United States are also found in the Dutch health care system. According to a 2019 study, the overall number of prescription opioid users in the Netherlands has nearly doubled between 2008 and 2017, and the number of opioid-related hospital admissions has tripled. READ MORE